Medistim ASA (OSL: MEDI)
Norway
· Delayed Price · Currency is NOK 141.00
+2.00 (1.44%)
Nov 21, 2024, 4:25 PM CET
Medistim ASA Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 101.64 | 103.82 | 113.97 | 90.9 | 69.39 | 70.31 | Upgrade
|
| Depreciation & Amortization | 22.56 | 23.66 | 23.29 | 23.43 | 16.25 | 18.01 | Upgrade
|
| Other Amortization | 2.44 | - | - | - | 6.89 | - | Upgrade
|
| Other Operating Activities | 10.08 | 5.69 | 12.91 | 9.83 | 3.17 | 1.78 | Upgrade
|
| Change in Accounts Receivable | 27.35 | 27.35 | -33.02 | -11.15 | 4.7 | 8.62 | Upgrade
|
| Change in Inventory | -31.06 | -31.06 | -16.92 | 15.25 | -22.6 | -26.23 | Upgrade
|
| Change in Accounts Payable | 0.61 | 0.61 | 11.27 | -0.32 | -1.3 | 2.89 | Upgrade
|
| Change in Other Net Operating Assets | -16.89 | -16.89 | 2 | -0.57 | -2.38 | 5.01 | Upgrade
|
| Operating Cash Flow | 116.74 | 113.19 | 113.49 | 127.37 | 74.13 | 80.38 | Upgrade
|
| Operating Cash Flow Growth | 9.30% | -0.27% | -10.90% | 71.82% | -7.77% | 44.07% | Upgrade
|
| Capital Expenditures | -16.4 | -16.4 | -9.25 | -7.4 | -7.45 | -13.68 | Upgrade
|
| Sale (Purchase) of Intangibles | -13.33 | -13.33 | -11.85 | -4.08 | -3.19 | - | Upgrade
|
| Investing Cash Flow | -32.4 | -29.73 | -21.1 | -11.49 | -10.64 | -13.68 | Upgrade
|
| Long-Term Debt Repaid | - | -8.71 | -7.31 | -12 | -9.68 | -8.77 | Upgrade
|
| Net Debt Issued (Repaid) | -8.71 | -8.71 | -7.31 | -12 | -9.68 | -8.77 | Upgrade
|
| Common Dividends Paid | -82.18 | -82.18 | -68.4 | -54.64 | -50.05 | -40.93 | Upgrade
|
| Other Financing Activities | 4.8 | 6.01 | 5.4 | 7.59 | 1.39 | 2.8 | Upgrade
|
| Financing Cash Flow | -86.09 | -84.88 | -70.3 | -59.05 | -58.35 | -46.9 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.65 | 2.65 | 1.07 | 0.76 | - | -0.55 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 0 | Upgrade
|
| Net Cash Flow | 0.9 | 1.23 | 23.15 | 57.6 | 5.15 | 19.26 | Upgrade
|
| Free Cash Flow | 100.34 | 96.79 | 104.24 | 119.97 | 66.68 | 66.7 | Upgrade
|
| Free Cash Flow Growth | 2.85% | -7.15% | -13.11% | 79.91% | -0.02% | 69.20% | Upgrade
|
| Free Cash Flow Margin | 18.52% | 18.57% | 21.44% | 28.71% | 18.72% | 18.69% | Upgrade
|
| Free Cash Flow Per Share | 5.48 | 5.29 | 5.70 | 6.57 | 3.66 | 3.66 | Upgrade
|
| Cash Income Tax Paid | 25.7 | 25.7 | 19.17 | 13.34 | 19.05 | 18.96 | Upgrade
|
| Levered Free Cash Flow | 61.04 | 64.71 | 56.39 | 98.98 | 47.3 | 51.23 | Upgrade
|
| Unlevered Free Cash Flow | 61.13 | 64.81 | 56.47 | 99.09 | 47.4 | 51.5 | Upgrade
|
| Change in Net Working Capital | 13.83 | 11.28 | 34 | -17.78 | 24.78 | 8.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.